title: The unfolded protein response in the therapeutic effect of hydroxy-DHA against Alzheimer's disease.
abstract: The unfolded protein response (UPR) and autophagy are two cellular processes involved in the clearing of intracellular misfolded proteins. Both pathways are targets for molecules that may serve as treatments for several diseases, including neurodegenerative disorders like Alzheimer's disease (AD). In the present work, we show that 2-hydroxy-DHA (HDHA), a docosahexaenoic acid (DHA) derivate that restores cognitive function in a transgenic mouse model of AD, modulates UPR and autophagy in differentiated neuron-like SH-SY5Y cells. Mild therapeutic HDHA exposure induced UPR activation, characterized by the up-regulation of the molecular chaperone Bip as well as PERK-mediated stimulation of eIF2α phosphorylation. Key proteins involved in initiating autophagy, such as beclin-1, and several Atg proteins involved in autophagosome maturation (Atg3, Atg5, Atg12 and Atg7), were also up-regulated on exposure to HDHA. Moreover, when HDHA-mediated autophagy was studied after amyloid-β peptide (Aβ) stimulation to mimic the neurotoxic environment of AD, it was associated with increased cell survival, suggesting that HDHA driven modulation of this process at least in part mediates the neuroprotective effects of this new anti-neurodegenerative drug. The present results in part explain the pharmacological effects of HDHA inducing full recovery of the cognitive scores in murine models of AD.
authors: Laboratory of Molecular Cell Biomedicine, Department of Biology, University of the Balearic Islands, Crta. Valldemossa km. 7.5, 07122, Palma de Mallorca, Spain.
authors: Manuel
authors: M
authors: Torres
authors: Amaia
authors: A
authors: Marcilla-Etxenike
authors: Maria A
authors: MA
authors: Fiol-deRoque
authors: Pablo V
authors: PV
authors: Escribá
authors: Xavier
authors: X
authors: Busquets
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000378:metabolism; D017209:Apoptosis; D001343:Autophagy; D045744:Cell Line, Tumor; D002470:Cell Survival; D004353:Drug Evaluation, Preclinical; D006801:Humans; D006880:Hydroxy Acids / Q000494:pharmacology* / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D056811:Unfolded Protein Response
chemical_list: D016229:Amyloid beta-Peptides; D006880:Hydroxy Acids; D018696:Neuroprotective Agents; C060440:2-hydroxydocosanoic acid